Recentin

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1988-2009
01219882009

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
PURPOSE The goal of this study was to examine the therapeutic potential of the vascular endothelial growth factor (VEGF… (More)
Is this relevant?
Review
2009
Review
2009
Angiogenesis, the process whereby tumors develop new blood vessels to facilitate growth and metastasis, is a pivotal event in… (More)
  • table 1
Is this relevant?
Review
2008
Review
2008
Cediranib (AZD2171; Recentin, AstraZeneca, Wilmington, Delaware) is a once-daily oral tyrosine kinase inhibitor that targets… (More)
Is this relevant?
2007
2007
  • Nature Reviews Cancer
  • 2007
 
Is this relevant?
Review
2007
Review
2007
There is an increasing body of evidence on the possible environmental influence on neurodevelopmental and neurodegenerative… (More)
Is this relevant?
2001
2001
Diabetic neuropathies, affecting the autonomic, sensory, and motor peripheral nervous system, are among the most frequent… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
1988
Review
1988
1. In vitro studies have indicated that several transmitters present in the striatum can regulate presynaptically the release of… (More)
  • table I
  • figure 1
  • figure 2
  • figure 3
Is this relevant?